Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity

Timothy M Coskran1, Zhijie Jiang2, James E Klaunig3

  • 1Drug Safety Research & Development, Pfizer Inc., Groton, Connecticut, United States of America.

Plos One
|May 5, 2017
PubMed

Insights

Species-specific liver tumors in mice may be driven by endogenous retroelements. Resistant mouse strains with robust immune responses may prevent tumor formation by clearing cells with activated retroelements.

Area of Science:

  • Toxicology
  • Genetics
  • Immunology

Background:

  • Species-specific chemical carcinogens pose a challenge in understanding tumor development.
  • The nongenotoxic rodent hepatic carcinogen WY-14,643 activates peroxisome proliferator-activated receptor alpha (PPARα).
  • Endogenous retroelements and immune responses are implicated in species-specific tumorigenicity.

Purpose of the Study:

  • To investigate the role of endogenous retroelements and immune responses in WY-14,643-induced liver tumorigenicity in mice.
  • To compare the effects of WY-14,643 in high (C3H/HeJ) and low (C57BL/6) liver tumor susceptible mouse strains.

Main Methods:

  • Treatment of male mice from C3H/HeJ and C57BL/6 strains with WY-14,643.
  • Analysis of endogenous retroelement expression (LTR and LINE elements).
  • Assessment of retroviral defense gene expression and immune-mediated viral defense.

Main Results:

  • WY-14,643 increased endogenous retroelement expression in both mouse strains.
  • Retroviral defense gene expression was elevated, particularly in the resistant C57BL/6 strain.
  • C57BL/6 mice exhibited enhanced basal and WY-14,643-induced immune-mediated viral defense.
  • The sensitive C3H/HeJ strain showed gene signatures of DNA recombination following WY-14,643 treatment.

Conclusions:

  • High endogenous retroelement activity in mice contributes to species-specific liver tumorigenicity.
  • A competent immune system in resistant strains like C57BL/6 can prevent tumors by eliminating cells with activated retroelements.
  • WY-14,643-induced DNA recombination in sensitive strains may facilitate tumor development.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.6K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.4K